Literature DB >> 7677180

Endotoxin stimulates expression of the murine urokinase receptor gene in vivo.

F Almus-Jacobs1, N Varki, M S Sawdey, D J Loskutoff.   

Abstract

The regulation of urokinase receptor (u-PAR) gene expression during endotoxemia was studied in vivo with a murine model system. Northern blot analysis demonstrated relatively high levels of u-PAR mRNA in mouse placenta, with intermediate levels in lung and spleen and very low levels in heart and kidney. No u-PAR mRNA could be detected in liver, gut, thymus, brain, or skeletal muscle. Intraperitoneal injection of endotoxin (lipopolysaccharide) increased the steady-state levels of u-PAR mRNA in most tissues examined. The greatest induction (sevenfold) was observed in the lung at 1 hour after injection. The cellular localization of u-PAR mRNA was assessed by in situ hybridization. In control mice, u-PAR mRNA was detected primarily in alveolar macrophages of the lung and lymphocytes of the spleen and thymus, although a specific signal was also present in other cell types. In general, endothelial cells lacked detectable u-PAR mRNA. The induction of u-PAR mRNA by lipopolysaccharide was apparent within 30 minutes and was localized to tissue macrophages, lymphocytes, and endothelial cells lining arteries and veins. At later times (1 to 3 hours), specialized epithelial cells present in gastrointestinal tract, bile ducts, and uterus were also positive for u-PAR mRNA. Induction of u-PAR in vivo by lipopolysaccharide may facilitate the extravasation and migration of leukocytes during inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677180      PMCID: PMC1870967     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Biochemistry of endotoxins.

Authors:  C R Raetz
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

2.  The urokinase-type plasminogen activator receptor is a member of the Ly-6 superfamily.

Authors:  R G Palfree
Journal:  Immunol Today       Date:  1991-05

3.  IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes.

Authors:  J C Kirchheimer; Y H Nong; H G Remold
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

4.  The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.

Authors:  N Behrendt; E Rønne; M Ploug; T Petri; D Løber; L S Nielsen; W D Schleuning; F Blasi; E Appella; K Danø
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

5.  Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization.

Authors:  P Kristensen; J Eriksen; K Danø
Journal:  J Histochem Cytochem       Date:  1991-03       Impact factor: 2.479

6.  Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.

Authors:  A P Sappino; J Huarte; J D Vassalli; D Belin
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.

Authors:  A F Suffredini; P C Harpel; J E Parrillo
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

Review 8.  Plasminogen receptors in the mediation of pericellular proteolysis.

Authors:  E F Plow; L A Miles
Journal:  Cell Differ Dev       Date:  1990-12-02

9.  Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.

Authors:  P Mignatti; R Mazzieri; D B Rifkin
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

10.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.

Authors:  A Estreicher; J Mühlhauser; J L Carpentier; L Orci; J D Vassalli
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

View more
  7 in total

1.  Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.

Authors:  N P Juffermans; P E Dekkers; A Verbon; P Speelman; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Physiology and pathophysiology of the plasminogen system in the kidney.

Authors:  Per Svenningsen; Gitte Rye Hinrichs; Rikke Zachar; Rikke Ydegaard; Boye L Jensen
Journal:  Pflugers Arch       Date:  2017-06-27       Impact factor: 3.657

3.  Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.

Authors:  P E Dekkers; T ten Hove; A A te Velde; S J van Deventer; T van Der Poll
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Urokinase type plasminogen activator receptor expression in colorectal neoplasms.

Authors:  S Suzuki; Y Hayashi; Y Wang; T Nakamura; Y Morita; K Kawasaki; K Ohta; N Aoyama; S R Kim; H Itoh; Y Kuroda; W F Doe
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

5.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.

Authors:  K Yamamoto; D J Loskutoff
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

6.  Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.

Authors:  Heng Wang; John Hicks; Parham Khanbolooki; Sun-Jin Kim; Chunhong Yan; Yao Wang; Douglas Boyd
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis.

Authors:  A R Kitching; S R Holdsworth; V A Ploplis; E F Plow; D Collen; P Carmeliet; P G Tipping
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.